LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 42 filers reported holding LOXO ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $14,226,000 | -8.6% | 169,000 | 0.0% | 0.56% | -20.1% |
| Q3 2017 | $15,568,000 | -22.7% | 169,000 | -32.7% | 0.70% | -34.7% |
| Q2 2017 | $20,141,000 | -36.5% | 251,167 | -66.7% | 1.07% | -12.2% |
| Q1 2017 | $31,699,000 | +293.2% | 753,300 | +200.1% | 1.22% | +268.4% |
| Q4 2016 | $8,061,000 | +22.7% | 251,000 | 0.0% | 0.33% | +8.5% |
| Q3 2016 | $6,571,000 | +12.9% | 251,000 | 0.0% | 0.31% | +33.6% |
| Q2 2016 | $5,818,000 | -15.2% | 251,000 | 0.0% | 0.23% | -21.6% |
| Q1 2016 | $6,862,000 | -3.9% | 251,000 | 0.0% | 0.29% | +1.0% |
| Q4 2015 | $7,141,000 | -62.5% | 251,000 | -76.9% | 0.29% | -60.7% |
| Q3 2015 | $19,022,000 | -27.2% | 1,088,225 | -25.0% | 0.74% | -15.5% |
| Q2 2015 | $26,146,000 | +32.0% | 1,450,151 | -8.9% | 0.87% | +35.7% |
| Q1 2015 | $19,815,000 | +6.0% | 1,591,546 | 0.0% | 0.64% | -4.5% |
| Q4 2014 | $18,701,000 | -10.5% | 1,591,546 | 0.0% | 0.67% | -11.8% |
| Q3 2014 | $20,897,000 | – | 1,591,546 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |